GEIST:UPC Searchengine

ORD_43746/2024

Abbott Diabetes Care Inc.

Datum
2024-07-26
Kammer
Luxembourg (LU)
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_43746-2024-7beb87e98dd4
Aktenzeichen
RegisterzeichenORD_43746/2024
EntscheidungsreferenzORD_43746/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 26 July 2024 concerning an application pursuant to R.9 RoP Application to disregard the submitted auxiliary requests APPLICANT / APPELLANT / CLAIMANT IN THE MAIN PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE Abbott Diabetes Care Inc., Alameda, California, USA, hereinafter also referred to as “Abbott” represented by: Eelco Bergsma, Attorney at law, Taylor Wessing, Eindhoven, the Netherlands RESPONDENTS / DEFENDANTS IN THE MAIN PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE 1. Sibio Technology Limited, Cambridge, United Kingdom 2. Umedwings Netherlands B.V., Cambridge, United Kingdom hereinafter also referred to as “Respondents” both represented by: Thomas Gniadek, Thomas Gniadek, Rechtsanwalt, Simmons & Simmons LLP, Munic ...